Anzeige
Mehr »
Login
Mittwoch, 30.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Desert Gold Ventures: Diese Goldaktie ist ein TOP-Übernahmekandidat
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QNK3 | ISIN: US25432X1028 | Ticker-Symbol: 0NW
NASDAQ
30.10.24
19:27 Uhr
31,140 US-Dollar
+0,400
+1,30 %
1-Jahres-Chart
DIME COMMUNITY BANCSHARES INC Chart 1 Jahr
5-Tage-Chart
DIME COMMUNITY BANCSHARES INC 5-Tage-Chart
PR Newswire
60 Leser
Artikel bewerten:
(0)

Chain Bridge Bancorp, Inc. Announces Launch of Initial Public Offering

MCLEAN, Va., Sept. 30, 2024 /PRNewswire/ -- Chain Bridge Bancorp, Inc. ("Chain Bridge"), the bank holding company for Chain Bridge Bank, National Association, today announced the launch of its initial public offering of 1,850,000 shares of its Class A common stock. Chain Bridge expects to grant the underwriters a 30-day option to purchase up to an additional 277,500 shares of its Class A common stock at the public offering price, less underwriting discounts. The initial public offering price is currently expected to be between $24.00 and $26.00 per share of Class A common stock. Chain Bridge's Class A common stock has been approved for listing on the New York Stock Exchange under the ticker symbol "CBNA", subject to official notice of issuance.

Chain Bridge intends to use the net proceeds from the offering primarily for general corporate purposes (which may include supporting continued organic deposit growth and funding potential strategic expansion) and to repay the $10 million outstanding principal balance under its unsecured line of credit.

Piper Sandler & Co., Raymond James & Associates, Inc., and Hovde Group, LLC are acting as book-running managers for the offering. Copies of the preliminary prospectus relating to the offering may be obtained from:

Piper Sandler & Co., Prospectus Department Phone: (800) 747-3924
Email: [email protected]

Raymond James & Associates, Inc., Syndicate Phone: (800) 248-8863
Email: [email protected]

Hovde Group, LLC, Syndicate Phone: (866) 971-0961
Email: [email protected]

A registration statement on Form S-1 relating to these securities has been filed with the Securities and Exchange Commission (the "SEC"), but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations, or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About Chain Bridge Bancorp, Inc.

Chain Bridge Bancorp, Inc., a Delaware corporation, is the registered bank holding company for Chain Bridge Bank, National Association. Chain Bridge Bancorp, Inc. is regulated and supervised by the Federal Reserve under the Bank Holding Company Act of 1956, as amended. Chain Bridge Bank, National Association is a national banking association, chartered under the National Bank Act, and is subject to primary regulation, supervision, and examination by the Office of the Comptroller of the Currency. Chain Bridge Bank, National Association is a member of the Federal Deposit Insurance Corporation (FDIC) and provides banking, trust, and wealth management services.

Company Contact:
Rachel G. Miller
Senior Vice President, Counsel and Corporate Secretary
Chain Bridge Bancorp, Inc.
[email protected]
703-748-3427

Forward Looking Statements

This communication contains forward-looking statements within the meaning of the U.S. federal securities laws. Forward-looking statements involve risks and uncertainties. You should not place undue reliance on forward-looking statements because they are subject to numerous uncertainties and factors relating to our operations and business, all of which are difficult to predict and many of which are beyond our control. Forward-looking statements include information concerning our possible or assumed future results of operations, including descriptions of our business strategy. These forward-looking statements are generally identified by the use of forward-looking terminology, including the terms "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and, in each case, their negative or other variations or comparable terminology and expressions. Actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements. Any forward-looking statements presented herein are made only as of the date of this press release, and Chain Bridge does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, new information, the occurrence of unanticipated events, or otherwise, except as required by law.

We have filed a registration statement on Form S-1 (including a preliminary prospectus) with the SEC for the offering to which this communication relates. Before making any investment decision, investors are urged to carefully read the preliminary prospectus in that registration statement, any amendments or supplements to the preliminary prospectus, and other documents we have filed with the SEC for more complete information about us and the proposed offering.

Investors may view the registration statement and preliminary prospectus on the SEC's website at www.sec.gov. Please note that the registration statement has not yet become effective.

SOURCE Chain Bridge Bancorp, Inc.

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.